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The intestinal mucosa contains large numbers 
of  mononuclear  cells,  including  macrophages 
and DCs, which together are believed to play a 
central role in regulating mucosal innate and 
adaptive immune responses in both the steady-
state and inflammatory setting (Kelsall, 2008). 
Expression of CD11c and CD11b has been used 
to distinguish DC subsets from macrophages in 
the  intestine.  However,  separating  subsets  of 
mononuclear cells based on CD11c is compli-
cated because this marker is also expressed on tis-
sue macrophages (Hume, 2008). Furthermore, 
there is currently little evidence to suggest that 
subdividing  mononuclear  lamina  propria  (LP) 
cells (LPCs) based on CD11c and CD11b de-
fines populations with distinct turnover rates, 
origins, and functional properties.
Based on the observation that DC can pen-
etrate epithelial monolayers in vitro and a close 
association of CD11c-expressing cells with the 
gut epithelium in vivo, Rescigno et al. (2001) 
put  forward  the  idea  of  epithelial-associated 
DC that is capable of capturing luminal bacte-
ria and transporting them into the intestinal LP. 
Further studies using transgenic mice express-
ing GFP under the control of the CX3CR1-
promoter (CX3CR1+/GFP mice) confirmed that 
a major subset of mononuclear cells in the in-
testinal LP are capable of extending processes 
across the epithelial layer into the intestinal lu-
men (Niess et al., 2005). In vivo invasion-defec-
tive  Salmonella  enterica  were  associated  with 
CX3CR1-expressing cells in the intestinal LP   
of  transepithelial-proficient,  but  not  transepi-
thelial dendrite-deficient, CX3CR1GFP/GFP mice, 
suggesting that transepithelial dendrites play an 
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Chemokine receptor CX3CR1+ dendritic cells (DCs) have been suggested to sample intestinal 
antigens by extending transepithelial dendrites into the gut lumen. Other studies identified 
CD103+ DCs in the mucosa, which, through their ability to synthesize retinoic acid (RA), 
appear to be capable of generating typical signatures of intestinal adaptive immune re-
sponses. We report that CD103 and CX3CR1 phenotypically and functionally characterize 
distinct subsets of lamina propria cells. In contrast to CD103+ DC, CX3CR1+ cells represent 
a nonmigratory gut-resident population with slow turnover rates and poor responses to 
FLT-3L and granulocyte/macrophage colony-stimulating factor. Direct visualization of cells 
in lymph vessels and flow cytometry of mouse intestinal lymph revealed that CD103+ DCs, 
but not CX3CR1-expressing cells, migrate into the gut draining mesenteric lymph nodes 
(LNs) under steady-state and inflammatory conditions. Moreover, CX3CR1+ cells displayed 
poor T cell stimulatory capacity in vitro and in vivo after direct injection of cells into 
intestinal lymphatics and appeared to be less efficient at generating RA compared with 
CD103+ DC. These findings indicate that selectively CD103+ DCs serve classical DC functions 
and initiate adaptive immune responses in local LNs, whereas CX3CR1+ populations might 
modulate immune responses directly in the mucosa and serve as first line barrier against 
invading enteropathogens.
© 2009 Schulz et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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results  suggest  a  division  of  labor  between  gut-resident 
CX3CR1+ LPC and migratory antigen-presenting CD103+ 
DC in the intestinal immune system.
RESULTS
CX3CR1 and CD103 identify nonoverlapping subsets of LP 
mononuclear cells
Defining  LP  mononuclear  cell  subsets  based  on  MHCII, 
CD11b, and CD11c is complicated because of variations in 
the expression levels of these markers, resulting in often over-
lapping and uncertain definitions of cell populations (unpub-
lished data; Chieppa et al., 2006; Uematsu et al., 2006, 2008). 
Because a prominent subset of LPC, which is capable of ex-
tending cellular processes through the gut epithelium, has 
been described using CX3CR1+/GFP mice (Niess et al., 2005; 
Vallon-Eberhard et al., 2006), we used CX3CR1+/GFP mice 
to assess CX3CR1, MHCII, CD11c, and CD103 expression 
on LPC by confocal microscopy and flow cytometry. Consis-
tent with a putative function in antigen sampling, CX3CR1/
GFP+ cells localized close to the intestinal epithelium (Fig. 1 
A). In confocal microscopy, CX3CR1/GFP+ LPC showed 
variable expression of CD11c and no expression of CD103 
(Fig. 1 A). In contrast, CD103 was evident as CD11cbright 
LPC with no detectable expression of CX3CR1/GFP (Fig. 1 
A) and these cells preferentially localized in the villus core   
(Fig.  1  A).  Enumeration  of  CX3CR1/GFP+  and  CD103+ 
CD11c+ LPC revealed roughly three- to fourfold more cells   
of  the  former  compared  with  the  latter  LPC  population   
(Fig.  1  A).  These  observations  suggest  that  CD103  and 
CX3CR1/GFP  identify  nonoverlapping  subtypes  of  small   
intestinal LPC.
Flow cytometry of isolated LPC confirmed these observa-
tions. The CD103+ LPC population comprised a substantial 
fraction  of  MHCII+CD11c+  cells  that  showed  very  weak 
CX3CR1/GFP signals (Fig. 1 B and Fig. S1 A). LPC express-
ing CX3CR1/GFP levels that potentially might be detected 
by fluorescent microscopy could be divided into two distinct 
populations distinguished by high and intermediate CX3CR1/
GFP expression (Fig. 1 B). Freshly isolated CX3CR1/GFPhigh 
LPCs were MHCII+CD11b+. These cells also expressed the 
macrophage markers CD14 and F4/80 and most expressed 
CD11c,  although  at  consistently  lower  levels  than  CD103+ 
MHCII+ cells. Based on these markers, CX3CR1/GFPhigh cells 
appear to represent a homogenous LPC population (Fig. 1 B  
and Fig. S1 B). Although the majority of CX3CR1/GFPint  
LPC  also  expressed  MHCII  and  CD11b,  this  population   
appeared phenotypically more heterogeneous. Although most 
CX3CR1/GFPint  LPC  expressed  F4/80  and  CD14,  albeit   
at lower levels than CX3CR1/GFPhigh cells, this population   
also contained a variable proportion of MHCII cells that were 
predominantly GR-1hiCD11b+CD11c CD62L+ CCR2high,  a 
phenotype which is similar to that of circulating inflammatory 
monocytes (Fig. 1 B, Fig. S1C, and not depicted; Landsman 
et al., 2007). For brevity, we refer to CD103+MHCII+CD11
c+CX3CR1 LPC as CD103+ DC. Because CX3CR1/GFP-
expressing LPCs share phenotypic traits with both macrophages 
important role in sampling and uptake of luminal microbes 
(Niess et al., 2005; Hapfelmeier et al., 2008). Such transepi-
thelial dendrites have also been observed in CD11c and MH-
CII reporter mice (Niess et al., 2005; Chieppa et al., 2006) 
even though their frequency and distribution remains con-
troversial (Chieppa et al., 2006; Vallon-Eberhard et al., 2006). 
Together, these studies have led to the prevailing assumption 
that epithelial-associated CX3CR1+ mononuclear LPCs are 
DCs that play an important role in the initiation of intestinal 
adaptive immune response (Rescigno, 2003; Chieppa et al., 
2006; Niess and Reinecker, 2006). Nevertheless, definitive 
evidence that CX3CR1+ LPCs are tissue DCs that are capable 
of migrating to draining mesenteric LN (MLN) and priming 
T cell responses has not been provided.
We, and others, have identified a subset of DC in the in-
testinal LP and MLN which expresses the integrin  chain 
CD103. These cells display an intrinsic ability to induce the 
gut-homing receptors CCR9 and 47-integrin on respond-
ing T cells (Annacker et al., 2005; Johansson-Lindbom et al., 
2005)  and  FoxP3  Treg  differentiation  in  vitro  (Coombes   
et al., 2007; Sun et al., 2007). Both of these functions appear 
to be caused by an enhanced ability of intestinal CD103+ DC 
to induce retinoic acid (RA) receptor signaling in respond-
ing T cells (Jaensson et al., 2008; Svensson et al., 2008) and   
are associated with higher expression of the gene encoding 
RALDH2 (retinaldehyde dehydrogenase 2), aldh1a2 (Coombes 
et al., 2007), a key enzyme involved in retinal metabolism. 
Importantly, CD103+ DCs are also present in human MLN 
and selectively induce RA receptor–dependent CCR9 ex-
pression on allogenic T cells (Jaensson et al., 2008). Thus, ex-
pression of CD103 identifies a DC subset that, under the 
influence of environmental conditioning in the gut and in 
the MLN (Agace, 2008; Hammerschmidt et al., 2008), con-
fers typical properties of intestinal immune responses. CD103+ 
DCs are dramatically reduced in the MLN, but not LP, of 
CCR7/  mice  (Johansson-Lindbom  et  al.,  2005;  Worbs   
et al., 2006) and, in BrdU pulse-chase experiments, have 
been shown to turn over rapidly in the LP in the steady state 
and  with  delayed  kinetics  in  the  MLN,  suggesting  that 
CD103+ MLN DCs represent LP-derived migratory DCs 
(Jaensson et al., 2008). Finally, CD103+, but not CD103, 
MLN DCs are capable of priming OT-I and OT-II cells ex 
vivo after oral administration of OVA, indicating that these 
cells play a central role in initiating T cell responses to soluble 
luminal antigen (Coombes et al., 2007; Jaensson et al., 2008). 
Despite these findings, it remains unclear whether intestinal 
CD103+ DC and CX3CR1+ cells represent phenotypically 
and functionally overlapping or distinct populations of cells 
in the intestinal LP.
In this paper, we demonstrate that CD103 and CX3CR1 
expression  defines  distinct  LPC  populations.  Although 
CD103+ DCs are short lived, travel via intestinal lymph to 
the gut draining MLN, and efficiently present antigens to na-
ive T cells, CX3CR1+ cells are comparably longer lived LP-
resident cells, cannot be observed in intestinal lymph, and are 
poor at presenting antigen to naive T cells. Together, these JEM VOL. 206, December 21, 2009 
Article
3103
Figure 1.  CX3CR1 and CD103 characterize distinct sets of LP mononuclear cells. (A) 50-µm cryosections of CX3CR1+/GFP mice were stained for 
CD11c and CD103 and analyzed by confocal microscopy. The image shows an orthogonal projection of a 7.5-µm z-stack depicting CX3CR1/GFP (green), 
CD103 (red), and CD11c (blue). The boxed region is shown in detail in split channels. The dashed lines indicate the epithelial border/basal lamina. Bar, 10 µm. 
The localization of CX3CR1/GFP+ and CD103+CD11c+ cells in the proximal ileum with respect to the basal epithelium and their numbers were determined 
using 7-µm-thick cryosections documented by epifluorescence microscopy. Diagrams depict mean and 25th and 75th percentiles as boxes. Sections ob-
tained from four mice in two independent experiments were evaluated and a total of 116 CD103+ and 584 CX3CR1+ cells were analyzed. ***, P < 0.001.  
(B) Flow cytometric analysis of CX3CR1+/GFP LPCs. CD103+ DCs express very low levels of CX3CR1 and were identified by subgating the CD103+CX3CR1/low 
population on CD11c+MHCII+ cells. CD11clow/MHCII cells in this plot are removed when gating on CD3CD19 cells, suggesting they are T cells (not 
depicted). CX3CR1+ LPCs could be further subgrouped into CX3CR1int and CX3CR1high LPC populations. All three populations were analyzed for expression 
of CD11b and F4/80. Numbers indicate mean percentage (SD) of cells in the respective gate of 10 mice analyzed in at least four independent experiments. 
The total percentage of CD103+ DC among CD45+ cells is 1.9% (SD, 1).
and DC, we will refer to these cells either as CX3CR1high  
or CX3CR1int LPC or summarize both populations as CX3- 
CR1+ LPC.
CX3CR1+ LPC and CD103+ DC display distinct turnover rates 
in the steady state and responsiveness to growth factors
By performing small bowel transplantations, we have recently 
reported that maintenance of the CD103+ DC compartment 
requires continual influx of precursors from extraintestinal sour-
ces (Jaensson et al., 2008). However, in sections from these trans-
plants we noted that CD11c+ cells displaying weak MHCII 
expression showed long-term persistence in grafted intestinal 
fragments (Fig. 2 A; Jaensson et al., 2008). Because CX3CR1+ 
LPCs show detectable CD11c expression (Fig. 1 A) when ana-
lyzed by immunofluorescence microscopy, we speculated that 
the CD11c+ cells that were maintained in the transplants 3104 CD103+ but not CX3CR1+ cells migrate in lymph | Schulz et al.
almost 10% of CD103+ DC had incorporated BrdU (Fig. 2 C). 
In contrast, both CX3CR1int and CX3CR1high LPCs showed 
significantly lower rates of BrdU incorporation (Fig. 2 C). Fi-
nally, to determine the impact of different DC/myeloid cell 
growth factors on CX3CR1+ LPC and CD103+ DC compart-
ments in vivo, CX3CR1+/GFP mice were injected with mela-
noma  cells  constitutively  secreting  Flt3L  or  GM-CSF  and, 
after 6–12 d, the numbers of CX3CR1+ LPCs and CD103+ 
DCs were determined by fluorescence microscopy and flow 
cytometry. CD103+ DCs efficiently expanded in mice carrying 
either Flt3L (Fig. 3, A and B) or GM-CSF–producing tumors 
(Fig. 3 B). In contrast, CX3CR1high LPC failed to respond to 
either cytokine, whereas CX3CR1int LPC showed expansion 
to Flt3L. Collectively, these results demonstrate that CD103+ 
DC and CX3CR1+ LPC display different turnover rates and 
responses to Flt3L and GM-CSF and, thus, likely derive from 
distinct precursor populations.
represented CX3CR1+ LPC. To assess this possibility, a small 
intestinal fragment, including the draining MLN, was isolated 
from CX3CR1/GFP mice and transplanted into syngenic WT 
recipients. 9 d after transplantation, the frequency of CX3CR1+ 
LPC in the grafted intestinal fragment was determined by   
immunofluorescence microscopy and compared with non-
transplanted CX3CR1/GFP mice. Strikingly, and in marked 
contrast to CD103+ DCs (Jaensson et al., 2008), CX3CR1+ 
LPCs were not reduced in the grafted small intestine com-
pared with unmanipulated CX3CR1+/GFP mice (Fig. 2 B). 
This indicates that CX3CR1+ LPCs are not rapidly replaced 
from extraintestinal sources, even though surgery might pro-
mote loss of cells from the transplanted tissue. To compare the 
turnover of CX3CR1+ LPC and CD103+ DC in the steady 
state, CX3CR1+/GFP mice were injected with a single dose of 
BrdU. Consistent with our observation that these cells turn 
over rapidly in vivo (Jaensson et al., 2008), 9 h after injection 
Figure 2.  CX3CR1+ LPCs, but not CD103+ DCs, display long-term persistence in small bowel transplants. (A) CD45.2+ intestinal fragments were 
grafted into CD45.1+ recipients and analyzed by fluorescence microscopy. 6 d after transplantation, the majority of CD11c+MHCII+ (arrows) cells in the 
grafted tissue did not express CD45.2, i.e., had been replaced by host cells. In contrast, CD11c+ cells with low MHCII signal (arrowheads) were mostly 
CD45.2+, which is indicative of donor origin and long-term persistence in the grafted tissue. Bars, 50 µm. Six mice were analyzed in six experiments.  
(B) Intestinal fragments were grafted from CX3CR1+/GFP donors into WT recipients. 9 d after transplantation, the number of CX3CR1/GFP+ cells in the 
grafted tissue was enumerated by epifluorescence microscopy and compared with unmanipulated CX3CR1+/GFP mice (control). Error bars represent SD. 
Bars, 20 µm. Two mice were analyzed in two experiments. (C) CX3CR1+/GFP mice were injected i.p. with 2 mg BrdU and, 9 h later, the percentage of BrdU-
positive CD103+ DC and CX3CR1+ LPC was determined by flow cytometry. Six mice were analyzed in three independent experiments. Error bars represent 
SEM. Results were obtained with a Wilcoxon signed rank test. *, P < 0.05.JEM VOL. 206, December 21, 2009 
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CD103+ DCs are a migratory population of cells that con-
tinually migrate to the draining MLN (Johansson-Lindbom 
et al., 2005; Hammerschmidt et al., 2008; Jaensson et al., 
2008). To directly determine whether CD11c+ DCs and/
or CX3CR1+ LPCs migrate from the small intestine to the 
MLN, we performed multiphoton confocal microscopy on 
CD103+ DCs, but not CX3CR1+ LPCs, migrate  
in intestinal lymph
A paradigmatic view of the DC life cycle is that immature 
DCs sample antigen in the periphery, mature, and migrate 
via the lymphatics into the draining LNs to present anti-
gen.  We  have  previously  provided  indirect  evidence  that 
Figure 3.  CX3CR1+ LPC and CD103+ DC display different responsiveness to Flt3L and GM-CSF in vivo. Melanoma cells secreting Flt3L or GM-
CSF were injected subcutaneously into CX3CR1+/GFP mice and animals were sacrificed 6–12 d later. (A) 12 d after injection of Flt3L-secreting tumor cells, 
confocal microscopy revealed massive expansion of intestinal CD103+ DC but not CX3CR1+ LPC. Images show representative stainings for CX3CR1/GFP 
(green), CD103 (red), and CD11c (blue). The boxed region in split channels is shown on the bottom. Arrowheads indicate CD11c+CD103+ LP DC and arrows 
mark CD11cCD103+ cells, most likely representing T cells. Three mice were analyzed in three independent experiments. Bars, 20 µm. (B) The total number 
of isolated CD103+ DC, CX3CR1high LPC, and CX3CR1int LPC in tumor-bearing mice was determined by flow cytometry. Mean (SD) is shown of at least six 
mice per group analyzed in two (GM-CSF) and three (Flt3L) independent experiments. Results were obtained with an unpaired Student’s t test. **, P < 
0.01; ***, P < 0.001.3106 CD103+ but not CX3CR1+ cells migrate in lymph | Schulz et al.
mesenteric lymph vessels. Lymph vessels were readily identi-
fied in olive oil–fed mice as whitish vessels running in paral-
lel to mesenteric blood vessels (Fig. 4 A; Hammerschmidt 
et al., 2008). To facilitate identification of lymph vessels by 
fluorescence microscopy, we injected fluorescently labeled 
dextran 30 min before sacrificing the mice. Fluorescently 
labeled  dextran  selectively  highlights  blood  vessels  shortly 
after i.v. injection, whereas 30 min after injection, blood 
and lymph vessels are both labeled (Fig. 4 A). Lymph ves-
sels were readily visible by bright-field microscopy, TRITC 
fluorescence signal, and a second harmonics signal, visual-
izing the collagen-rich vessel wall. Cells present in the ves-
sel lumen appeared as dark TRITC-excluding shadows (Fig. 
4 B). Using mice expressing enhanced YFP (EYFP) under 
control of the CD11c promoter (CD11c-EYFP mice), we 
readily identified CD11c-expressing cells in intestinal lymph 
Figure 4.  R848 administration mobilizes CD11c/YFP+, but not CX3CR1/GFP+, cells into MLN-afferent lymph. (A) Visualization of MLN-afferent 
lymphatics. 1 h after gavage of 200 µl of olive oil, lymphatics appear as bright/white vessels running in parallel to mesenteric blood vessels (left). FITC- and 
TRITC-labeled dextran injected i.v. 2 and 30 min before analysis (green and red, respectively) can differentially highlight blood vessels or both blood vessels 
and lymphatics. In the merge (right) image, blood vessels appear yellow and lymph vessels red. Bar, 1 mm. (B) Two-photon microscopy of MLN-afferent 
lymphatics of CD11c-EYFP and CX3CR1+/GFP mice in the steady state or 5 h after oral administration of R848. TRITC-labeled dextran was injected i.v. 30 min 
before mice were sacrificed to visualize the vessel lumen (red). Collagen-rich vessel walls display a second harmonic signal (blue). The images show orthog-
onal projections of 20-µm-thick (CD11c-EYFP mice) or 5-µm-thick (CX3CR1/GFP mice) volumes. Bars, 50 µm. CD11c-positive cells were readily detectable in 
steady-state lymphatics (top left, green) and in increased numbers 5 h after gavage of 10 µg R848 (bottom left). CX3CR1-positive cells typically occurred  
in the shape of stellate morphology cells on the outside of vessel tubes or within the vessel wall (top right). Cells not expressing the reporter GFP/YFP ap-
peared as TRITC-excluding shadows in the lumen. Pictures shown are from non–Peyer’s Patch draining lymphatics. The following numbers of independent 
experiments were each performed with single mice: CD11c-EYFP, five; CD11c-EYFP+R848, two; CX3CR1+/GFP, four; and CX3CR1+/GFP+R848, five.JEM VOL. 206, December 21, 2009 
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typic  analysis  of  CD11c+  cells  demonstrated  homogenous 
expression of CD103 and very weak expression of CX3CR1 
and, hence, these cells phenotypically resembled intestinal 
CD103+ DC. In striking contrast to CD103+ DC, we failed 
to detect CX3CR1high cells in lymph preparations irrespec-
tive  of  R848  application.  Furthermore,  the  frequency  of 
CX3CR1int  cells  did  not  increase  upon  R848  treatment. 
Thus, in lymph isolated after R848 treatment <50 cells could 
be isolated expressing intermediate levels of CX3CR1, <20% 
(10 cells) of which coexpressed MHCII. Given the virtually 
complete absence of CX3CR1/GFP cells observed in lymph 
vessels by microscopy and the close association of CX3CR1+ 
cells with the lymph wall, it seems likely that these cells are 
contaminants from surrounding tissue. However we cannot, 
at this point, rule out that a few CX3CR1int cells expressing 
CX3CR1 levels too low to be detected by microscopy might 
enter intestinal lymph. Concomitant with the appearance of 
CD103+ DC in intestinal lymph, 16 h after oral R848 or i.p. 
LPS administration there was a marked decrease in CD103+ 
DC in the intestinal LP and accumulation of these cells in the 
MLN (Fig. 5 B and not depicted). In contrast, the numbers 
of CX3CR1high and CX3CR1int cells in the LP and MLN 
remained  unchanged.  In  particular,  no  CX3CR1high  cells 
could be observed in MLN irrespective of TLR stimulation. 
Finally, the inability of CX3CR1+ cells to migrate into lymph 
correlated  with  an  inability  of  these  cells  to  up-regulate 
CCR7 12 h after in vitro stimulation with LPS (Fig. S2). 
vessels (Fig. 4 B, top left). CD11c/YFP+ cells in lymph ves-
sels showed a rounded morphology, and careful analysis of 
Z-stacks confirmed intraluminal localization as judged by the 
collagen/SHG  signal.  CD11c/EYFP-expressing  cells  were 
scarce but could be demonstrated in almost all image stacks 
analyzed (unpublished data). Extending these experiments to 
CX3CR1+/GFP mice, CX3CR1/GFP-expressing cells were 
detectable in surrounding fatty tissue, either as scattered cells 
or in compact cell clusters (not depicted), and occasionally 
on the extraluminal side of the lymph vessels (Fig. 4 B, top 
right; and Video 1). This latter population displayed stellate 
cell morphology and in some cases extended protrusions into 
the lymph vessel. However, in striking contrast to CD11c/
EYFP+ cells, CX3CR1/GFP+ cells were almost undetectable 
within intestinal lymph vessels (Video 1). Of four mice ana-
lyzed, only in one case were a total of four CX3CR1/GFP-
expressing cells observed in the lymph vessel lumen.
R848  signaling  via  Toll-like  receptor  (TLR)  7/8  en-
hances the migration of DC from the LP into the MLN (Yrlid 
et al., 2006). Such R848-induced mobilization of DC is ac-
companied by a massive increase in serum levels of proin-
flammatory cytokines and does not depend on direct TLR 
stimulation on the DC (Yrlid et al., 2006). We thus used oral 
R848 application to investigate the presence of CD11c- and 
CX3CR1-expressing cells in intestinal lymph under inflam-
matory conditions. 5 h after oral administration of R848 to 
CD11c-EYFP mice, the number of CD11c/EYFP+ cells in 
intestinal  lymph  was  markedly  increased  compared  with 
steady-state conditions (Fig. 4 B, bottom left; and Video 2). 
Oral application of R848 to CX3CR1+/GFP mice, however, 
failed  to  mobilize  CX3CR1+  cells  into  intestinal  lymph   
(Fig. 4 B, bottom right). Thus, direct visualization of CD11c- 
and CX3CR1-expressing cells in intestinal lymph revealed 
that CD11c+, but not CX3CR1+, cells migrate in intestinal 
lymph  under  steady-state  as  well  as  under  inflammatory 
conditions.
To further characterize the CD11c+ cells present in intes-
tinal lymph, we established a novel technique, to isolate cells 
from  murine  intestinal  lymph  vessels  for  flow  cytometric 
analysis. CX3CR1+/GFP mice received olive oil by gavage 
and, 1 h later, intestinal lymph vessels were carefully cannu-
lated with a fine capillary. By collecting lymph from several 
vessels in each mouse, this method allowed us to isolate a to-
tal volume of 0.2–0.4 µl of lymph per mouse (unpublished 
data). In the steady state, no CX3CR1high cells were detect-
able in intestinal lymph and <2% of all cells were CD11c+ 
MHCII+  or  expressed  intermediate  levels  of  CX3CR1/ 
GFP. Because of the low numbers of isolated cells, we were 
unable to further phenotype these populations. In contrast, 5 h 
after R848 administration up to 40% of all viable cells were 
CD11c+MHCII+  cells  (Fig.  5  A).  Importantly,  such  cells 
were not observed in intestinal lymph of chemokine receptor 
CCR7-deficient mice after R848 administration (Fig. 5 A), 
which is consistent with a central role of CCR7 for DC mi-
gration into draining LNs (Ohl et al., 2004; Johansson-Lindbom 
et al., 2005; Hintzen et al., 2006; Worbs et al., 2006). Pheno-
Figure 5.  R848 administration mobilizes CD103+ DC, but not 
CX3CR1+ LPC, into MLN-afferent lymph. (A) Lymph was collected 
from MLN-afferent vessels 5 h after oral administration of R848 and ana-
lyzed by flow cytometry. MHCII+CD11c cells express CD19 and, most 
likely, represent B cells exiting from GALT (not depicted). Results are rep-
resentative of six experiments. (B) Frequencies of CD103+ DC, CX3CR1int 
LPC, and CX3CR1high LPC 16 h after oral administration of R848 as deter-
mined by flow cytometry. CX3CR1high LPCs were not detected (n.d.) in the 
MLN. Cell numbers observed in untreated mice were normalized to 1. Bars 
indicate the according fold change of the mean. Errors bars indicate SD. 
Four mice per group were analyzed in two independent experiments. Re-
sults were obtained with an unpaired Student’s t test. **, P < 0.01.3108 CD103+ but not CX3CR1+ cells migrate in lymph | Schulz et al.
Collectively, these results demonstrate that, in contrast to 
CD103+ DCs, CX3CR1+ LPCs are a nonmigratory popula-
tion of cells in the LP and are thus unlikely to participate in 
the  initiation  of  adaptive  immune  responses  in  intestinal 
draining LN.
CX3CR1+ LPCs are inefficient at priming naive T cells  
in vitro and in vivo
Besides their migratory properties, the most distinguishing 
feature of DCs is their potent antigen-presenting capacity. 
We therefore isolated CD103+ DC, CX3CR1int LPC, and 
CX3CR1high LPC and analyzed their ability to present anti-
gen to CD4+ and CD8+ T cells. Isolated cell populations 
were loaded in vitro with OVA peptide specific for MHC 
class I–restricted OT-I or MHCII-restricted OT-II T cells. 
As expected, peptide-loaded CD103+ DC induced efficient 
proliferation of OT-I and OT-II cells (Fig. 6 A; Johansson-
Lindbom et al., 2005). In contrast, CX3CR1int LPC showed   
a significantly reduced ability to activate OT-I.RAG/ T 
cells and, in particular, OT-II.RAG/ T cells. CX3CR1high 
LPC induced only very weak proliferation of OT-I.RAG/ 
T cells and failed to induce OT-II.RAG/ or OT-II prolif-
eration (Fig. 6 A and not depicted). Notably, all three LPC   
populations  expressed  the  costimulatory  molecules  CD40, 
CD80, and CD86 (Fig. S3 A). Under steady-state conditions, 
CD103+ DCs isolated from LP expressed significantly lower 
levels of CD40 and CD86 compared with CD103+ DCs   
isolated from the MLN (unpublished data). This situation 
changed when CD103+ DCs were isolated from the LP after 
R848 treatment, resulting in increased expression of CD40 
and CD86 (Fig. S3 B). However, such up-regulation was less 
evident on CX3CR1+ LPC (Fig. S3 B), and reduced induc-
tion of costimulatory molecules might at least partly explain 
the low ability of these cells to stimulate T cells.
Because in vitro peptide loading does not recapitulate the 
entire process of antigen uptake, processing, and presentation, 
we injected OVA-Cy5 into exteriorized intestinal loops of 
CX3CR1+/GFP mice to load cells with antigen in vivo. Flow 
cytometry revealed a higher proportion of antigen-positive 
CX3CR1+ LPC compared with CD103+ DC, indicating that 
CX3CR1+ LPC readily took up soluble fluorescently labeled 
OVA  in  vivo  (Fig.  6  B).  Nevertheless,  in  vivo–loaded 
CX3CR1+ LPCs were much less efficient in priming OT-II 
T cells compared with CD103+ DCs (Fig. 6 B). Notably, in 
CX3CR1GFP/GFP mice, lacking functional CX3CR1 protein, 
GFP+ LPC also took up fluorescently labeled OVA and adop-
tively transferred OT-II T cells were activated in the MLN of 
these mice as efficiently as in WT recipients (Fig. S4, A and B). 
Because  these  mice  fail  to  extend  transepithelial  dendrites 
(Niess et al., 2005), these results indicate that transepithelial 
dendrites are dispensable for uptake of and induction of T cell 
responses to oral soluble antigen.
Compared with the complex situation in an LN, in vitro 
co-cultures can only recapitulate some aspects of T cell ac-
tivation. Therefore we investigated the antigen-presenting 
capacity of CD103+ DC compared with CX3CR1+ LPC in 
Figure 6.  CX3CR1+ LPCs fail to efficiently induce T cell prolif-
eration in vitro and in vivo. (A) OT-I or OT-II cells were co-cultured 
with peptide-loaded CD103+ DC, CX3CR1int LPC, or CX3CR1high LPC at a 
ratio of 10:1 for 3 d. Proliferation was determined by thymidine incor-
poration assay and is depicted as a percentage of the mean T cell pro-
liferation in CD103+ DC co-cultures (thymidine index). Results are the 
mean (SEM) of three or more independent experiments using pooled 
cells from four to five mice per experiment. Data were analyzed using 
one sample Student’s t test, compared with CD103+ DC. Co-cultures of 
LPC/T cells at a 1:2 ratio showed a similarly inefficient induction of T 
cell proliferation compared with the 1:10 ratio (not depicted). *, P < 
0.05; **, P < 0.01; ***, P < 0.001. (B) 500 µg of unlabeled or Cy5-labeled 
OVA was injected into the gut lumen of anaesthetized CX3CR1+/GFP 
mice. 1 h later, mice were sacrificed and Cy5 fluorescence in CD103+ 
DC and CX3CR1+ LPC was determined by flow cytometry. Dot plots are 
gated on CD103+ DC or MHCII+CX3CR1+ LPC as indicated. Gates were 
adjusted to contain 0.1% of positive cells in controls  
(injected with unlabeled OVA) and numbers indicate the proportion  
of Cy5-positive cells. Data are representative of five mice analyzed in 
three independent experiments. CD103+ DC and CX3CR1high LPC from 
OVA-Cy5–injected mice were sorted 1 h after injection and co- 
cultured with OT-II T cells for 3 d at a ratio of 1:10. Cells were pulsed 
with 1 µCi [3H]thymidine 18 h before collection, and thymidine incor-
poration was quantified in a  counter. Bars represent pooled data 
obtained in two independent experiments. Error bars indicate SEM. 
Results were obtained with a one-sample Student’s t test. ***, P < 
0.001. (C) 107 CFSE-labeled DO11.10 cells were adoptively transferred 
to BALB/c recipients. 1 d later, 5,000 peptide-loaded CD103+ DCs or 
CX3CR1+ LPCs were injected into the MLN-afferent lymphatics. Prolif-
erating antigen-specific T cells were detected in the MLN 3 d after 
injection. Plots are gated on live CD4+ cells. Control mice received 20 
mg OVA by gavage. Results are representative of two independent 
experiments.JEM VOL. 206, December 21, 2009 
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vivo. Sorted CD103+ DC and CX3CR1+ LPC were loaded 
with OVA peptide specific for MHCII- restricted DO11.10 
T cells, and 5,000 antigen-loaded cells were injected into the 
MLN-afferent lymph of recipient mice that previously re-
ceived CFSE-labeled DO11.10 cells i.v. 3 d after intralym-
phatic injection, T cell proliferation was determined in MLN 
and peripheral LNs. Injection of CD103+ DC induced pro-
liferation of antigen-specific DO11.10 T cells in the MLN 
but not in peripheral LNs (Fig. 6 C and not depicted). In   
contrast,  antigen-loaded  CX3CR1+  LPC  failed  to  induce 
DO11.10 T  cell  proliferation  in  the  MLN.  Notably,  the   
injected CX3CR1+ LPC included CX3CR1high and CX-
3CR1int LPC that showed weak but measurable CD4 T cell 
priming capacity in vitro (Fig. 6 A). Together, these results 
demonstrate that compared with CD103+ DCs, CX3CR1int 
LPCs and, in particular, CX3CR1high LPCs have only mod-
est antigen-presenting capacity in vitro and in vivo.
CX3CR1+ LPCs are not imprinted with an enhanced ability 
to metabolize vitamin A
Given recent studies suggesting an important role for intesti-
nal epithelial cells in imprinting CD11c+ with the ability to me-
tabolize vitamin A and generate gut tropic T cells (Edele et al., 
2008; Iliev et al., 2009), and the proximity of CX3CR1+ LPC 
to the intestinal epithelium, we assessed whether these cells 
were imprinted with the ability to generate RA. Real-time 
PCR analysis demonstrated that both CX3CR1int and CX-
3CR1high LPC expressed significantly lower levels of aldh1a2 
compared with CD103+ DC (Fig. 7 A). To assess whether 
such differences correlated with differences in aldehyde de-
hydrogenase (ALDH) activity, CD103+ DC and CX3CR1+ 
cells were incubated with the fluorescent ALDH substrate 
ALDEFLUOR, and ALDH activity was assessed by flow cy-
tometry. Because the ALDEFLUOR signal emitted in the 
FITC channel, we focused on CX3CR1high cells that, in con-
trast  to  CX3CR1int,  were  readily  identified  in  WT  mice   
by  gating  on  F4/80+MHCIIhighCD11bhigh  cells  (Fig.  S5). 
CD103+ DC exhibited significantly higher ALDH activity, 
compared with CX3CR1high cells, that was blocked with the 
ALDH inhibitor DEAB (diethylaminobenzaldehyde; Fig. 7, 
B and C). Finally, to assess whether these differences resulted 
in a reduced ability of CX3CR1+ LPC to induce CCR9 on 
responding T cells, CFSE-labeled OT-I cells were incubated 
together with peptide-pulsed CX3CR1high and CX3CR1int 
LPCs, and their expression of CCR9 was assessed by flow 
cytometry. In contrast to CD103+ DC (Fig. 7 D; Johansson-
Lindbom et al., 2005; Jaensson et al., 2008), peptide-pulsed 
CX3CR1int and, in particular, CX3CR1high LPCs were inef-
ficient at inducing CCR9 on responding T cells (Fig. 7 D). 
Together, these results suggest that CX3CR1+ LPCs are not 
locally imprinted with an enhanced ability to generate the   
vitamin A metabolite RA.
DISCUSSION
A paradigm has arisen during the last few years postulating 
that intestinal LPCs actively sample intestinal antigens through 
transepithelial dendrites and that such a process might drive 
the induction of intestinal immune responses in the gut drain-
ing MLN. Support for such a model came from numerous 
studies that, on the one hand, demonstrated transepithelial 
dendrite-forming cells in live tissue and on the other hand 
described functional properties of antigen-presenting cells in 
the LP and draining MLN. However, the interrelation of   
antigen-sampling cells in the LP and antigen-presenting cells 
in the MLN has not been directly investigated. Transepithe-
lial dendrite-forming LPCs have mostly been visualized by 
GFP expressed under control of the CX3CR1 or CD11c 
promoter (Niess et al., 2005; Chieppa et al., 2006; Vallon-
Eberhard et al., 2006), whereas CD103 has been used as a 
surrogate marker to identify LP-derived DC in the MLN 
(Annacker et al., 2005; Johansson-Lindbom et al., 2005).
In this study, we used immunofluorescence microscopy 
and flow cytometry to demonstrate that CD103+ DC and 
CX3CR1+ LPC represent phenotypically distinct cell popu-
lations in the LP. CX3CR1+ LPC outnumbered CD103+ 
cells three- to fourfold and, in contrast to CD103+ DC, locali-
zed close to the epithelium, which is consistent with previous 
results (Niess et al., 2005; Chieppa et al., 2006). CX3CR1+ 
LPC could be further divided into CX3CR1high and CX-
3CR1int LPC populations by flow cytometry. CX3CR1high 
Figure 7.  CX3CR1+ LPCs display weak ALDH activity and fail to 
efficiently induce CCR9 on responding CD8 T cells. (A) Aldh1a2 ex-
pression of sorted CD103+ DC, CX3CR1int LPC, and CX3CR1high LPC was 
assessed by real-time PCR. The mean (horizontal lines) was obtained from 
three separate experiments using pooled cells from five to eight mice per 
experiment. Results were obtained with an unpaired Student’s t test.  
**, P < 0.01; ***, P < 0.001. (B and C) ALDH activity on sorted CD103+ DC 
and MHCII+F4/80+CD11b+ LPC with or without addition of inhibitor.  
(B and C) Representative stainings (B) and mean (C; horizontal lines) of 
five individual mice (symbols). Results were obtained with a paired Stu-
dent’s t test. **, P < 0.01. (D) CFSE-labeled OT-I cells were co-cultured with 
peptide-loaded CD103+ DC, CX3CR1high LPC, or CX3CR1int LPC at a ratio of 
2:1 for 3.5 d and expression of CCR9 on responding OT-I cells was ana-
lyzed. Results are representative of two experiments.3110 CD103+ but not CX3CR1+ cells migrate in lymph | Schulz et al.
Using confocal microscopy, no CX3CR1+ cells were ob-
served in lymph under steady-state and inflammatory condi-
tions.  In  contrast,  CD11c+  cells  were  readily  visible  and 
dramatically increased in numbers after R848 administration. 
Flow cytometry confirmed the absence of CX3CR1high cells 
in intestinal lymph and revealed that the overwhelming ma-
jority of CD11c+MHCII+ cells in lymph were CD103+ and, 
thus, indistinguishable from CD103+ DC in the LP. Con-
sistently, oral administration of R848 or i.p. administration of 
LPS (unpublished data) induced a loss of CD103+ DCs from 
the intestinal LP and a corresponding increase of these cells   
in  the  MLN,  whereas  CX3CR1+  cell  numbers  remained   
unchanged.  These  findings  are  consistent  with  studies  in 
LysM-Cre x ROSA26floxstopfloxGFP mice, suggesting that the 
majority of CX3CR1+ cells in the MLN do not derive from 
the intestinal LP (Bogunovic et al., 2009), and previous stud-
ies examining lymph migrating DC in adenectomized rats and 
pigs (Pugh et al., 1983; Bimczok et al., 2005; Milling et al., 
2006), indicating that only a subset of myeloid LPC is capable 
of  entering  draining  lymph  vessels  (Bimczok  et  al.,  2005;   
Yrlid et al., 2006). Moreover, they offer a plausible explana-
tion for the failure in previous studies to observe epithelial- 
associated CD11c+ cells leaving the LP (Chieppa et al., 2006).
Although we failed to detect CX3CR1+ cells in lymph 
by confocal microscopy, CX3CR1int cells were detected in 
low but variable numbers in lymph preparations. We cannot 
at this point rule out that these few cells derive from the LP; 
however, CX3CR1+ cells were readily visualized in the fat 
tissue surrounding the lymph vessels and occasionally had   
protrusions extending into the lymph vessel. We thus assume 
that the few CX3CR1int cells in lymph preparations were 
contaminants from CX3CR1-expressing cells in intimate con-
tact with the vessel wall. Furthermore, the few MHCII+ cells 
within this population would seem highly unlikely to be in 
meaningful enough numbers to participate in initiation of   
T cell responses in the MLN.
To  determine  whether  CX3CR1+  LPC  and  CD103+ 
DC displayed direct functional differences in their ability to 
drive  characteristic  intestinal T  cell  responses,  we  assessed 
their ability to prime T cell responses in vitro and in vivo. 
CD103+ DCs were more efficient antigen-presenting cells 
compared with CX3CR1int and CX3CR1high LPC. Differ-
ences  in  antigen-presenting  capacity  were  generally  more 
pronounced in CD4+ compared with CD8+ T cell priming, 
in vivo versus in vitro assays, and CD103+ DC compared 
with CX3CR1high LPC. Moreover, these populations dif-
fered in their ability to generate RA, a central signaling mol-
ecule involved in shaping the signature of intestinal T cell 
responses.  CX3CR1+  LPCs  expressed  significantly  lower 
levels of aldha1a2, displayed low ALDH activity, and were 
poor at inducing CCR9 on responding T cells in comparison 
with CD103+ DC. These latter findings are somewhat sur-
prising given the current dogma that DCs are conditioned by 
adjacent  epithelial  cells  and  recent  studies  suggesting  that   
intestinal epithelial cells induce aldha1a2 on bone marrow–
derived DCs and imprint them with an ability to induce 
LPCs, which represent the large majority of CX3CR1+ cells 
in the LP, appeared as a homogenous population of cells ex-
pressing CD11b, F4/80, and CD14, markers which are fre-
quently  used  to  identify  macrophages.  Although  most 
CX3CR1int LPCs also expressed CD11b and F4/80, their 
variable expression of MHCII, CD11c, and CD14 suggested 
that this population consisted of several subsets of cells or cells 
at various stages of maturation.
In addition to their distinct phenotypes, CD103+ DC and 
CX3CR1+ LPC differed in their responsiveness to growth 
factors and turnover rates, suggesting that they derive from di-
stinct precursors. CD103+ DC expanded in response to Flt3L 
and GM-CSF, whereas CX3CR1high LPC failed to expand   
in response to these cytokines. Moreover, CX3CR1+ cells 
showed  slower  turnover  rates  in  vivo  and,  in  contrast  to 
CD103+ DC, were not replaced by recipient cells in small 
intestinal grafts. These results are consistent with two recent 
articles that were published while this manuscript was under 
review (Bogunovic et al., 2009; Varol et al., 2009). Bogunovic 
et al. (2009) demonstrated an important role for Flt3L and 
GM-CSF  in  the  generation  of  CD103+  DC  but  not 
CD103MHCII+CD11c+CD11b+ cells, the large majority of 
which are CX3CR1+ (unpublished data), and showed that 
the former cells could derive from pre-DC, whereas the latter 
derive from Ly6Chi monocytes. Similarly, Varol et al. (2009) 
demonstrated that Flt3L expanded CD103+CD11b DCs, 
the majority of which likely derive from intestinal isolated 
lymphoid tissues. However, their findings regarding respon-
siveness of CD11c+CD11b+ cells to GM-CSF and Flt3L are 
difficult to interpret, as this population likely includes both 
CD103+CD11b+  DCs,  which  make  up  the  majority  of 
CD103+  DCs  in  the  LP,  and  CD11c+CX3CR1+  LPCs. 
These  authors  also  demonstrated  that  CX3CR1int  and   
CX3CR1high cells derived from monocytes, whereas grafted 
pre-DCs predominantly gave rise to CD11c+CX3CR1 cells. 
It is of note that both these studies focused on the fraction   
of CX3CR1high cells that expressed sufficient levels of CD11c 
to fall within the CD11chighMHCIIhigh DC gate. However, 
our current results suggest that these cells are otherwise phe-
notypically identical to the CD11cCX3CR1high cells and 
should not be interpreted to represent classical DCs or a dis-
tinct subset of CX3CR1high cells.
Given previous studies suggesting that CX3CR1+ cells 
capture luminal antigen for initiation of immune responses 
(Niess et al., 2005; Chieppa et al., 2006; Niess and Reinecker, 
2006; Vallon-Eberhard et al., 2006; Hapfelmeier et al., 2008; 
Uematsu et al., 2008) and indirect evidence indicating that at 
least a proportion of CD103+ MLN DC derive from the in-
testinal LP (Johansson-Lindbom et al., 2005; Hammerschmidt 
et al., 2008), we used two novel technical approaches, multi-
photon confocal microscopy of intact lymph vessels and isola-
tion of lymph cells, to determine whether these populations 
migrated in intestinal lymph. Using these methods, we provide 
direct evidence to suggest that CD103+ DCs are the dominant 
migratory DC population in the LP, whereas CX3CR1high 
LPCs  represent  a  nonmigratory  tissue  resident  population. JEM VOL. 206, December 21, 2009 
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For the future, it will be important to interpret the func-
tion of myeloid LPCs based on the anatomical constraints of 
the intestinal immune system. CX3CR1+ LPCs capable of 
antigen presentation in vitro are unlikely to encounter naive 
T cell in vivo because naive T cells are mostly restricted to 
GALT and MLN and only pass through the LP very infre-
quently. In this regard, our use of CD103 and CX3CR1 as 
surrogate markers to define lymph migrating and gut-resident 
cells is likely to provide an important tool for further dissec-
tion of the functionality of LPC subsets.
Although we suggest that CX3CR1+ LPCs do not act as 
classical DC-priming T cells in draining LN, our data do not 
rule out a potential role for these cells in modulating the 
adaptive immune responses. For example, CX3CR1+ LPCs 
that have been shown to engulf luminal bacteria (Niess et al., 
2005; Hapfelmeier et al., 2008) and take up orally adminis-
tered soluble proteins (this study) may directly pass antigenic 
material to CD103+ DC still localized in the LP. In this re-
spect,  a  recent  study  reported  localization  of  noninvasive   
S. enterica within CX3CR1+ cells in the cecum early after in-
fection, whereas at later time points S. enterica were observed 
within CX3CR1 cells (Hapfelmeier et al., 2008). Interest-
ingly, uptake of soluble antigen from the intestinal lumen   
was intact in CX3CR1GFP/GFP mice, indicating that transepi-
thelial extensions would not contribute to sampling of soluble 
antigen. Moreover, given recent results that antigen-present-
ing cells drive cytokine and proliferative responses of effector/
memory T cells in peripheral tissues (Wakim et al., 2008; 
McLachlan et al., 2009), antigen presentation by CX3CR1+ 
LPC may regulate cytokine production and function of anti-
gen-specific effector T cells subsequent to their entry into the 
intestinal LP. Alternatively, the central role of CX3CR1+ 
LPC may simply be to serve as a first line of defense by 
phagocytosing and killing bacteria on the epithelial surface or 
within the intestinal LP. Consistent with such a function, flag-
ellated  S.  enterica  was  recently  shown  to  induce  MyD88- 
dependent  CX3CR1+  cell  migration  into  the  intestinal 
lumen, suggesting a role for these cells in cell-mediated im-
mune exclusion (Arques et al., 2009).
In summary, our data suggest a division of labor between 
migrating LP DCs and gut-resident CX3CR1+ cells. CD103+ 
DCs are capable of intralymphatic migration and enter MLN. 
In the MLN, cell- and tissue-intrinsic influences, including 
RA, cooperate to shape the induction of intestinal immune re-
sponses. Although future studies are required to determine the 
potentially diverse in vivo functions of CX3CR1+ LPCs, the 
realization that these cells represent a gut-resident LP myeloid 
population will allow more focused efforts toward this goal.
MATERIALS AND METHODS
Mice. B6.129P-CX3CR1tm1Litt/J (Jung et al., 2000; CX3CR1+/GFP mice on 
C57BL/6 background), BALB/c.129P- CX3CR1tm1Litt/J (CX3CR1GFP/GFP 
and CX3CR1+/GFP mice on BALB/c background), B6.129P2(C)-Ccr7tm1Rfor/
J (CCR7/ mice [Förster et al., 1999]), C57BL/6-Tg(Tcra Tcrb)1100MjbJ 
(OT-I  mice  and  OT-I  mice  crossed  to  RAG-2–deficient  background), 
C57BL/6-Tg(Tcra  Tcrb)425Cbn-Ptprca  (OT-II  Ly5.1  mice  and  OT-II 
gut-homing receptors on responding T cells (Edele et al., 
2008; Iliev et al., 2009). A likely explanation for our findings 
is that epithelial-associated CX3CR1+ LPCs, in contrast to 
CD103+ DCs, respond poorly to such imprinting signals or 
that epithelial-derived factors alone are insufficient for such 
imprinting. It is important to note that our results do not ex-
clude the possibility that intestinal epithelial cells modulate 
the functionality of LP-resident cell populations, but they sug-
gest that the ability to metabolize retinol is not part of this im-
printing program.
An operational definition of a tissue DC should stress the 
function of DC in transporting antigen and information ob-
tained in peripheral tissues to the draining LNs to activate   
T cells. Judged by such measure, our results demonstrate that 
CD103+CD11c+MHCII+ cells fulfil all characteristics of clas-
sical tissue DC. In referring to these cells as DCs, it is of rele-
vance to emphasize “their unique life cycle, acting as sentinels 
in peripheral tissues that on tissue or microbial signals carry 
self- and foreign antigens to draining lymphoid tissues for the 
induction of T cell tolerance and immunity” (Kelsall, 2008). 
In contrast, defining CX3CR1+ LPCs is more problematic 
because these cells did not migrate in intestinal lymph, dis-
played weak antigen-presenting capacity in comparison with 
CD103+ DCs, and share phenotypical traits of both macro-
phages and DCs.
The question thus arises as to the function of CX3CR1+ 
LPC in the intestinal mucosa. Numerous publications have 
examined the antigen-presenting capacity of LP macrophages 
and DCs and the quality of the ensuing immune response   
using in vitro co-culture assays (Laouar et al., 2005; Uematsu 
et al., 2006, 2008; Denning et al., 2007; Atarashi et al., 2008). 
However, a conclusive synopsis of these findings is compli-
cated because of the divergent strategies used to define dis-
tinct subsets of macrophages and DC. The recently described 
population of intestinal macrophages characterized by CD11b 
and  CD11c  appears  to  largely  overlap  with  CX3CR1high 
LPC (Denning et al., 2007). These cells have been reported 
to constitutively produce interleukin 10 and, similarly, we 
observed  intracellular  anti–interleukin  10  staining  in  CX-
3CR1high LPC (unpublished data). This indicates that consti-
tutive interleukin 10 production by CX3CR1high LPC might 
contribute to create a tolerance favoring environment in the 
small intestine.
DCs  and  macrophages  share  phenotypical  and  func-
tional  characteristics,  and  an  accentuated  point  of  view 
might regard DCs as macrophages that display a particular 
state of activation (Hume, 2008). Along this line, pheno-
typic descriptions appear to be insufficient to ascertain the 
nature  of  myeloid  LPCs.  In  particular,  the  widely  used 
markers CD11c and CD11b in our hands were unsuitable 
to distinguish CD103+ migratory DCs and CX3CR1+ gut-
resident LPCs (Fig. S1). Moreover, cells expressing typical 
macrophage markers such as F4/80 have been referred to   
as DCs or myeloid DC-like cells. Thus, some of the func-
tions assigned to DCs might belong to macrophages and 
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nM OVA 323–339 peptide (AnaSpec or Innovagen) for 1–2 h at 37°C, 
washed extensively, and co-cultured with OT-I or OT-II cells, respectively, 
in round bottom 96-well plates at a ratio of 1:10 (104 LPC/105 T cells).   
1 µCi [3H]thymidine was added after 24 h of co-culture and thymidine in-
corporation was measured 18 h later. To examine CCR9 induction, OVA 
257–264 peptide-pulsed CD103+ DCs, CX3CR1int LPCs, and CX3CR1high 
LPCs were co-cultured with CFSE-labeled OT-I cells at a ratio of 1:2 (5 × 
104 LPC/105 T cells) and CCR9 expression was assessed by flow cytometry 
after 3.5 d.
Cell transfer. 107 CFSE-labeled DO11.10 cells were adoptively transferred 
to BALB/c or CX3CR1GPF/GPF BALB/c mice. All mice received a single 
dose of 50 mg OVA grade III per gavage 4 h after transfer. Proliferation of 
transferred cells was analyzed on day 3.
Flt3L or GM-CSF–secreting B16 melanoma cells (Mach et al., 2000; 
provided by N. Mach, Geneva University Hospital, Geneva, Switzerland) 
were cultured in RPMI 1640 supplemented with 10% FCS, glutamine, and 
penicillin/streptomycin. Cells were washed thoroughly in PBS before trans-
fer. 5 × 106–107 cells were injected subcutaneously into each dorsal flank of 
the mice. Mice were sacrificed after 6–12 d and analyzed by histology and/or 
flow cytometry.
Flow cytometry. Flow cytometry was performed according to standard 
procedures. To assess BrdU incorporation, CX3CR1+/GFP mice received an 
i.p. injection of BrdU (2 mg per mouse; Sigma-Aldrich) and were sacrificed 
after 9 h. Isolated LPCs were stained with surface antibodies to CD11c, 
MHCII, CD45.2 and CD103. Live cells were identified using the Live Dead 
Fixable Violet Dead Cell stain kit (Invitrogen) according to the manufactur-
er’s instructions. Finally, cells were stained with PE-conjugated anti-BrdU 
antibody (PE BrdU Flow kit; BD) and analyzed on a FACSAria (BD). 
ALDH  activity  of  CD103+  LP  DC  and  CX3CR1hi  LPC  was  determined   
using  the  ALDEFLOUR  staining  kit  (STEMCELL  Technologies  Inc.)   
according to the manufacturer’s instructions. LPCs were suspended at 106 
cells/ml in ALDEFLUOR assay buffer containing activated ALDEFLUOR 
substrate (final concentration 1.5 µM) with or without the ALDH inhibitor 
DEAB  (final  concentration  15  µM)  and  incubated  at  37°C  for  30  min.   
ALDEFLUOR-reactive cells were detected in the FITC channel using a 
FACSAria. Propidium iodide was used to exclude dead cells.
Histological analysis. Intestinal tissue was fixed with cold paraformalde-
hyde (1% in PBS, pH 7.4) for 3 h and frozen in O.C.T. (Sakura). Cryosec-
tions of 7- or 50-µm thickness were stained with anti–CD11c-APC (HL3) 
and anti–CD103-PE (M290) diluted in TBS with 0.01% Tween at room 
temperature. Staining was documented using epifluorescence (BX61; Olym-
pus) or confocal laser-scanning (Meta; Carl Zeiss, Inc.) microscopy. Analysis D 
(Soft Imaging System) software was used to determine the location and   
frequency of LPCs. Z-stacks obtained by confocal laser-scanning microscopy 
were combined to volumes using Imaris (Bitplane).
Two-photon microscopy. Mice received 200 µl of olive oil per gavage   
(1  h  before  sacrifice)  and  400  µg  of  TRITC-labeled  dextran  i.v.  (MW 
70,000; Invitrogen; 30 min before sacrifice) to help the identification of 
lymphatics. Lymphatics were ligated with suture close to MLN under anes-
thesia with Ketamine/Rompun. Mice were sacrificed and a 5–8-cm-long 
intestinal segment corresponding to distal jejunum and proximal ileum with 
its intact connecting vessels and the MLN was dissected, glued into a cell 
culture dish, and submerged in cold PBS during the image acquisition to 
minimize peristaltic movement. Imaging was done on a TriM Scope (LaVi-
sion Biotec) equipped with an upright microscope (BX51; Olympus) fitted 
with a 20× 0.95 NA water immersion objective and a MaiTai Ti:sapphire-
pulsed laser (Spectra-Physics) tuned to 865 nm. Image stacks were combined 
to volumes using Imaris version 6.3.1 and the location of cells was analyzed 
using the orthoslicer function in XY and XZ direction. Orthogonal projec-
tions in Fig. 4 B were generated using two parallel clipping planes (steady-state 
CD11c-EYFP) or the orthoslicer function in XY direction with extended 
section (remaining images) to visualize the central 5–20 µm of a vessel.
mice crossed to RAG-2–deficient background), and BALB/c–Tg(DO11.10) 
(Do11.10 mice), C57BL/6, BALB/c were bred at the central animal facility 
of  Hannover  Medical  School  and/or  Biomedical  Center  animal  facility 
(Lund University, Lund, Sweden) under specified pathogen-free conditions. 
CD11c-EYFP (Lindquist et al., 2004) mice were provided by T. Veres 
(Fraunhofer Institut für Toxikologie und Experimentelle Medizin, Hannover, 
Germany). All animal experiments were performed in accordance with institu-
tional guidelines and have been approved by the review board of Hannover 
Medical School and the Niedersaechsische Landesamt für Verbraucherschutz 
und Lebensmittelsicherheit or by the Lund/Malmö Animal Ethics Committee.
Antibodies and reagents. The following antibodies and reagents were 
used: CCR9 (7E7; Pabst et al., 2004), CCR2 (MC-21; gift from M. Mack, 
University of Regensburg, Regensburg, Germany), CD11c-APC (HL3), 
CD103-PE (M290), CD45.2-PerCP-Cy5.5 (104), CD62L-APC (MEL-14), 
CD80-PE (16-10A1), CD86-PE (GL1), MHCII(1Ab)-biotin (AF6-120.1), 
MHCII(1Ad)-biotin (AMS-32.1), BrdU-PE (3D4), and rat IgG2b-biotin 
(G15-337; BD); MHCII(I-A/I-E)-APC (M5/114.15.2) and MHCII(I-A/I-
E)–Pacific blue (M5/114.15.2; BioLegend); DO11.10 TCR-bio (KJ1-26; 
Invitrogen); CCR7-PE (4B12), CD11b-APC-Cy7 (M1/70), CD11c-PE-
Cy7 (N418), CD14-APC (Sa2-8), CD103-PE, CD103-biotin (2E7), CD45-
PE-Cy7 (30-F11), CD45.2-APC-Cy7 (104), F4/80-APC (BM8), F4/80-PE 
(BM8), Gr-1-APC (RB6-8C5), Gr-1-PE-Cy7 (RB6-8C5), and Ly6C-bio-
tin (AL-21; eBioscience); and CD40-PE (1C10; Beckman Coulter). APC 
streptavidin conjugate, Qdot 605 streptavidin conjugate, and streptavidin 
Alexa Fluor 430 conjugate were obtained from Invitrogen. Dead cells were 
identified  using  DAPI  staining  (Roche),  propidium  iodine  (Invitrogen),   
7-amino-actinomycin d (Sigma-Aldrich), or Live Dead Fixable Violet Dead 
Cell  staining  kit  (Invitrogen).  CFSE  was  obtained  from  Sigma-Aldrich.   
Water-soluble R848 was obtained from InvivoGen and LPS (E. coli O26:B6) 
from Sigma-Aldrich. OVA grade III was purchased from Sigma-Aldrich.
Mouse surgery. Small bowel transplantation was performed as described 
previously (Pabst et al., 2005). 9 d after transplantation, mice were sacrificed 
and the grafted tissue was embedded for cryosectioning. Injection of OVA 
into the intestine was performed under the combined anesthesia with Ket-
amine and Rompun. The small intestine was exposed and 500 µg OVA or 
Cy5-labeled OVA were injected in 2 vol of 250 µl into the proximal and 
distal small intestine. The intestine was reintroduced into the body cavity 
and the skin closed with wound clips. Mice were maintained under anesthe-
sia for 1 h before sacrifice. Intralymphatic injection was performed as previ-
ously described (Hammerschmidt et al., 2008).
Cell isolation. For isolation of LPC, Peyer’s patches were excised and the 
intestine was opened longitudinally and incubated 3 × 15 min in HBSS with 
10% FCS and 2 mM EDTA at 37°C to remove epithelial cells. After each 
incubation step, tubes were shaken for 10 s and media containing epithelial 
cells and debris were discarded. The remaining tissue was incubated for   
45 min in RPMI 1640 with 10% FCS, 0.24 mg/ml collagenase A (Roche), 
and 40 U/ml DNase I (Roche; O. Pabst laboratory) or 0.25 mg/ml collage-
nase VIII (Sigma-Aldrich) and 50 mM CaCl2 (W.W. Agace laboratory), the 
tubes shaken for 10 s, and cell suspension collected. This step was repeated 
one more time and the pooled cell suspension were filtered and either puri-
fied by density gradient centrifugation with 40–70% Percoll (GE Healthcare; 
O. Pabst laboratory) or, alternatively (W.W. Agace laboratory), filtered consec-
utively through 100- and 40-µm cell strainers (BD). To isolate cells of MLN, 
LNs were cut into pieces and incubated in the collagenase media described in 
this section for 45 min and meshed through nylon gaze. Lymph was isolated 1 h 
after mice received 200 µl of olive oil per gavage to visualize intestinal lymphat-
ics. Mice were sacrificed, lymph was collected with a fine capillary and filtered, 
and the cellular fraction was washed two times with PBS containing 2% FCS.
Co-culture experiments. For thymidine incorporation assays, CD103+ 
DCs, CX3CR1int LPCs, and CX3CR1high LPCs were sorted to >95% pu-
rity, pulsed with 200 pM OVA 257–264 peptide (Innovagen) or with 560 JEM VOL. 206, December 21, 2009 
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Bogunovic, M., F. Ginhoux, J. Helft, L. Shang, D. Hashimoto, M. Greter, 
K. Liu, C. Jakubzick, M.A. Ingersoll, M. Leboeuf, et al. 2009. Origin 
of the lamina propria dendritic cell network. Immunity. 31:513–525. 
doi:10.1016/j.immuni.2009.08.010
Chieppa, M., M. Rescigno, A.Y. Huang, and R.N. Germain. 2006. Dynamic 
imaging of dendritic cell extension into the small bowel lumen in re-
sponse to epithelial cell TLR engagement. J. Exp. Med. 203:2841–2852. 
doi:10.1084/jem.20061884
Coombes, J.L., K.R. Siddiqui, C.V. Arancibia-Cárcamo, J. Hall, C.M. Sun, 
Y. Belkaid, and F. Powrie. 2007. A functionally specialized population 
of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF- 
and retinoic acid-dependent mechanism. J. Exp. Med. 204:1757–1764. 
doi:10.1084/jem.20070590
Denning, T.L., Y.C. Wang, S.R. Patel, I.R. Williams, and B. Pulendran. 
2007. Lamina propria macrophages and dendritic cells differentially in-
duce regulatory and interleukin 17-producing T cell responses. Nat. 
Immunol. 8:1086–1094. doi:10.1038/ni1511
Edele, F., R. Molenaar, D. Gütle, J.C. Dudda, T. Jakob, B. Homey, R. 
Mebius, M. Hornef, and S.F. Martin. 2008. Cutting edge: instructive 
role of peripheral tissue cells in the imprinting of T cell homing receptor 
patterns. J. Immunol. 181:3745–3749.
Förster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Müller,   
E. Wolf, and M. Lipp. 1999. CCR7 coordinates the primary immune 
response by establishing functional microenvironments in second-
ary lymphoid organs. Cell. 99:23–33. doi:10.1016/S0092-8674(00) 
80059-8
Hammerschmidt, S.I., M. Ahrendt, U. Bode, B. Wahl, E. Kremmer, R. 
Förster, and O. Pabst. 2008. Stromal mesenteric lymph node cells are 
essential for the generation of gut-homing T cells in vivo. J. Exp. Med. 
205:2483–2490. doi:10.1084/jem.20080039
Hapfelmeier, S., A.J. Müller, B. Stecher, P. Kaiser, M. Barthel, K. Endt, 
M. Eberhard, R. Robbiani, C.A. Jacobi, M. Heikenwalder, et al. 2008. 
Microbe  sampling  by  mucosal  dendritic  cells  is  a  discrete,  MyD88-
independent step in DeltainvG S. Typhimurium colitis. J. Exp. Med. 
205:437–450. doi:10.1084/jem.20070633
Hintzen,  G.,  L.  Ohl,  M.L.  del  Rio,  J.I.  Rodriguez-Barbosa,  O.  Pabst, 
J.R. Kocks, J. Krege, S. Hardtke, and R. Förster. 2006. Induction of 
tolerance to innocuous inhaled antigen relies on a CCR7-dependent 
dendritic cell-mediated antigen transport to the bronchial lymph node.  
J. Immunol. 177:7346–7354.
Hume,  D.A.  2008.  Macrophages  as  APC  and  the  dendritic  cell  myth.  
J. Immunol. 181:5829–5835.
Iliev, I.D., E. Mileti, G. Matteoli, M. Chieppa, and M. Rescigno. 2009. 
Intestinal  epithelial  cells  promote  colitis-protective  regulatory  T-cell 
differentiation through dendritic cell conditioning. Mucosal Immunol. 
2:340–350. doi:10.1038/mi.2009.13
Jaensson,  E.,  H.  Uronen-Hansson,  O.  Pabst,  B.  Eksteen,  J.  Tian,  J.L. 
Coombes, P.L. Berg, T. Davidsson, F. Powrie, B. Johansson-Lindbom, 
and W.W. Agace. 2008. Small intestinal CD103+ dendritic cells dis-
play unique functional properties that are conserved between mice and   
humans. J. Exp. Med. 205:2139–2149. doi:10.1084/jem.20080414
Johansson-Lindbom, B., M. Svensson, O. Pabst, C. Palmqvist, G. Marquez, 
R. Förster, and W.W. Agace. 2005. Functional specialization of gut 
CD103+ dendritic cells in the regulation of tissue-selective T cell hom-
ing. J. Exp. Med. 202:1063–1073. doi:10.1084/jem.20051100
Jung,  S.,  J.  Aliberti,  P.  Graemmel,  M.J.  Sunshine,  G.W.  Kreutzberg, 
A.  Sher,  and  D.R.  Littman.  2000.  Analysis  of  fractalkine  receptor   
CX(3)CR1 function by targeted deletion and green fluorescent pro-
tein reporter gene insertion. Mol. Cell. Biol. 20:4106–4114. doi:10.1128/ 
MCB.20.11.4106-4114.2000
Kelsall, B. 2008. Recent progress in understanding the phenotype and func-
tion  of  intestinal  dendritic  cells  and  macrophages.  Mucosal  Immunol. 
1:460–469. doi:10.1038/mi.2008.61
Landsman, L., C. Varol, and S. Jung. 2007. Distinct differentiation potential 
of blood monocyte subsets in the lung. J. Immunol. 178:2000–2007.
Laouar, A., V. Haridas, D. Vargas, X. Zhinan, D. Chaplin, R.A. van Lier, 
and N. Manjunath. 2005. CD70+ antigen-presenting cells control the 
proliferation and differentiation of T cells in the intestinal mucosa. Nat. 
Immunol. 6:698–706. doi:10.1038/ni1212
Real-time  PCR.  Total  RNA  was  isolated  from  LPC  subsets  using 
RNeasy  Micro  kit  (QIAGEN)  and  complementary  DNA  was  gener-
ated using Superscript III First-Strand kit (Invitrogen) with random hex-
amers. Expression of GAPDH and aldh1a2 was analyzed using the MyiQ 
Single-Color  Real-Time  PCR  Detection  System  (Bio-Rad  Laborato-
ries), the Maxima SYBR Green qPCR kit (Fermentas), and the follow-
ing primers: GAPDH forward, 5-CCTGCACCACCAACTGCTTA-3; 
GAPDH  reverse,  5-TCATACTTGGCAGGTTTCTCCA-3;  aldh1a2 
forward,  5-CAGATGCTGACTTGGACTAC-3;  and  aldh1a2  reverse, 
5-ATAAGCTCCAGGACTTTGTT-3.
Statistical analysis. Statistical analysis was performed with Prism software 
(GraphPad Software, Inc.) using an unpaired two-tailed Student’s t test, a 
paired two-tailed Student’s t test, a one-sample Student’s t test, or a Wil-
coxon signed rank test as indicated. Error bars represent SD or SEM as in-
dicated. Statistical differences for the mean values are indicated as follows:   
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
Online supplemental material. Fig. S1 demonstrates the phenotype of 
CD103+ DC and CX3CR1+ LPC under steady-state conditions. Fig. S2 
shows expression of CCR7 on CD103+ DC and CX3CR1+ LPC after 
LPS stimulation. Fig. S3 shows expression of costimulatory molecules on 
CD103+ DC and CX3CR1+ LPC under steady-state conditions and after 
R848 stimulation. Fig. S4 compares uptake of soluble OVA and activa-
tion of T cells in WT to CX3CR1GFP/GFP mice. Fig. S5 illustrates gating 
of CX3CR1+ LPC independent of CX3CR1/GFP reporter activity. Vid-
eos 1 and 2 illustrate occurrence of CX3CR1/GFP cells and CD11c/EYFP 
cells in intestinal lymph vessel in steady state and after R848 stimulation, 
respectively. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20091925/DC1.
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